Author: Jonathan Eisen
6/10 at #UCDavis: Workshop on “The Social Life of Medical Data”
The Social Life of Medical Data
A one-day workshop on sharing, pooling and appropriating medical information
http://icis.ucdavis.edu/?tribe_events=workshop-the-social-life-of-medical-data
Wednesday, June 10, 10 am to 5 pm
UC Davis campus (location TBA)
Once digitized, medical information – such as data, images, standards, and codes – travels across different spaces and communities. Smartphones produce and transmit data coming from our bodies, which is shared and discussed in social media platforms and then gathered and analyzed in data centers. Medical information intended for professional use can be appropriated, circulated and used to create communities of caring or participate in biomedical research. At the same time new power asymmetries can emerge, as public institutions and private corporations claim control over increasingly valuable health data.
In this one-day workshop we will analyze the trajectories of digitized medical data. We will discuss how patient communities, care providers, social activists, governments and corporations are designing, fostering and managing alternative approaches to healing and increasingly look towards open source, distributed, and participatory research to do this. Data created from bodies has the potential to expand our understanding of health-related research and scholarly communication practices.
In addition, we will explore different ways of including patient communities in participatory design of tools that assist in the management and analysis of health data. We aim to foster a discussion amongst anthropologists, media scholars and biomedical researcher about the emergent forms of sociality and the politics of health and illness in our digital era.
Speakers include:
Nick Anderson, UC Davis
Carlos Andres Barragan, UC Davis
Dav Clark, UC Berkeley
Alessandro Delfanti, UC Davis
Joe Dumit, UC Davis
Allison Fish, UC Davis
Marina Levina, University of Memphis
Hélène Mialet, UC Berkeley
Kim Surkan, MIT
Orkan Telhan, University of Pennsylvania
Detailed program TBA
Lunch will be served. Please RSVP at this link if you plan to attend http://bit.ly/1PxzbQ6
—
UC Davis Innovating Communication in Scholarship
icis.ucdavis.edu
Post-doctoral position in Human Microbiome Research and Women’s Health
POSTDOCTORAL POSITION BIOINFORMATICS & HUMAN MICROBIOME RESEARCH
The Institute for Genome Sciences at the University of Maryland School of Medicine encompasses an inter-disciplinary, multi-departmental team of collaborative investigators with a broad research program related to the genomics of infectious diseases, human microbial metagenomics, functional genomics, and bioinformatics.
TWO POSTDOCTORAL FELLOW positions are currently opened at the Institute for Genome Sciences for collaborative projects between Drs. Jacques Ravel and Rebecca Brotman. Qualified candidates will be enthusiastic, highly motivated and interested in studying the role of the human microbiome in relation to women’s health. The research in this position will focus on how the vaginal microbiome provides protection from sexually transmitted infections (STIs) and in the development of bacterial vaginosis (BV). Projects will apply computational, statistical and bioinformatics approaches on multi-omics’ datasets such as genome sequences, metabolomics, metagenomics, and metatranscriptomics.
The ideal applicant will possess a demonstrable understanding of bioinformatics and computational biology with a background in molecular biology, microbial ecology, statistics and/or molecular epidemiology. The candidate will have a doctoral degree in Genetics, Biology, Microbiology, Computer Science or a related field. Programming and statistical skills in languages such as Perl, Python, C/C++ and R, though not essential, are a plus.
Postdoctoral fellows at IGS benefit from a community of interactive research labs, bioinformatics experts and a variety of state of the art sequencing, and computational resources in a world-class institute dedicated to genomic, basic, and translational research.
To apply, please send a CV, a statement of research interests (2 pages maximum), and contact information for three references to IGS-jobs.
Additional inquiries about the position can be sent to Drs. Jacques Ravel and Rebecca Brotman
jravel@som.umaryland.edu
rbrotman@som.umaryland.edu
CPB Seminar at #UCDavis today: Environmental gradients and interactions with soil biota shape adaptation in teosinte
CPB Spring Quarter Seminar Reminder – Tuesday, May 19, 2015 – 4:10pm – 1022 Life Sciences
May 19: Anna O’Brien
Graduate Student, Population Biology Graduate Group, UC Davis
Title: “Environmental gradients and interactions with soil biota shape adaptation in teosinte”
Nice story from Dan Potter on KQED about Women Science PhDs
Nice story on KQED from Dan Potter: Women Getting Science Ph.D.s Still Face Gender Barriers
http://blogs.kqed.org/science/files/jw-player-plugin-for-wordpress/player/player.swf
At #UCDavis today Sam Diaz-Munoz, 11:15 am
Department of Microbiology & Molecular Genetics Recruitment Seminar
Samuel Diaz-Munoz, Ph.D.
(NYU)
"The Evolution of Viral Social Interactions"
Monday, May 18, 2015
11:15 am*
197 Briggs*
*note time and location
Talk at #UCDavis today: Michael Fischbach on Small molecules from the human microbiota – GBSF noon
Seminar today
“Insights from a global view of secondary metabolism: Small molecules from the human microbiota”
Michael Fischbach, Ph.D.
Assistant Professor, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco
Friday, May 15, 2015 12:10 – 1:00 PM
Genome and Biomedical Sciences Facility Auditorium (GBSF 1005)
Time to boycott Oxford Global meetings due to blatant sexism
I don’t even know what to say or do about this it is so stunningly pathetic. I saw this Tweet earlier in the day:
Oxford Global’s Pharmaceutical IT Congress: All 38 speakers male! (it seems)
http://t.co/ctu18mKLAw
@phylogenomics @GenderAvenger #YAMMM
— Elisabeth Bik (@MicrobiomDigest) May 13, 2015
I figured even in an era of blatant sexism in science, this must be a mistake right? How could there be a conference with 38 male speakers and 0 female speakers. So I went to the site: Who is Speaking – Oxford Global’s 13th Pharmaceutical IT Congress, September 2015. And, well, as far as I can tell Elisabeth Bik has the numbers right. (See a list at the end of this post). They even have a running slideshow of the speakers faces.
This is even worse than the 25:1 ratio of the qBio meeting I lost it over a few years ago. I have never seen anything like this. I note – a 38:0 ratio is nearly impossible by chance in any field and I think pretty clearly an indication of massive bias of some kind.
I note – this is not the first case of a mostly male meeting from Oxford Global. See for example:
Oxford Global Sequencing Meetings: Where MEN Tell You About Sequencing #YAMMM
I think it is time to just boycott meetings meetings from Oxford Global. The only way they will change is if people stop speaking at or going to their meetings. So please – stop going to their meetings. Stop speaking at their meetings.
Speakers 2015:
- Sebastien Lefebvre
Director Data Engineering and Technology – Global Data Office, Biogen Idec - Uwe Barlage
EDC Project Leader, Bayer Healthcare - Marc Berger
Vice President, Real World Data and Analytics, Pfizer - Michael Braxenthaler
Pharma Research and Early Development Informatics, Global Head Strategic Alliances, Roche, & President, Pistoia Alliance - Arnaub Chatterjee
Associate Director – Data Science, Insights and Partnerships, Merck - James Connelly
Global Head, Research Data Management, Sanofi - Jos Echelpoels
Director IT, Regional Initiatives, Janssen - Brian Ellerman
Head of Technology Scouting and Information Science Innovation, Sanofi - Peter Elsig Raun
Director & Head Business Analysis, Lundbeck - Dimitrios Georgiopoulos
Chief Scientific Officer UK, Novartis - Charles Gerrits
Vice President, Innovative Patient-Centric Endpoints and Solutions, Sanofi - Yike Guo
Professor of Computing Science, Imperial College London and Chief Technology Officer, tranSMART Foundation - Sergio H. Rotstein
Director, Research Business Technology, Pfizer - Juergen Hammer
Global Head Data Science, Center Head Pharma Research and Early Development Informatics, Roche - Jan Hauss
Head Central Analytics Informatics, Merck - Athula Herath
Statistical Director, Translational Sciences, MedImmune - Nigel Hughes
Director Integrative Healthcare Informatics, Janssen Research and Development - Michael Hvalsøe Brinkløv
BI Architect, IT Platforms & Infrastructure, Lundbeck - Robert J. Boland
Senior Manager, Translational Informatics & External Innovation R&D IT, Janssen - Adrian Jones
Associate Director, Business Intelligence Systems, Astellas - Srivatsan Krishnan
Director and Head of R&D Operations and IT, Bristol-Myers Squibb - Philippe Marc
Global Head of Preclinical Informatics, Novartis Institutes for Biomedical Research - Dermot McCaul
Director, Preclinical Development and Biologics IT, Merck - Pantaleo Nacci
Head Statistical Safety & Epidemiology/PV, Novartis Vaccine and Diagnostics Srl (a GSK company) - Gerhard Noelken
Global Business IT Lead for Pharmaceutical Science, Pfizer WRD - Emmanuel Pham
VP Biométrie, Ipsen - Andrew Porter
Director, Enterprise Architecture, Merck - Gabriele Ricci
Vice President of TechOpps IT, Shire - Anthony Rowe
Director, Translational Informatics and External Innovation, Johnson & Johnson - Martin Ryzl
Director, GIC Analytics Platform Engineering, Merck - Wolfgang Seemann
Senior Project Manager, Bayer Business Services - Aziz Sheikh
Professor of Primary Care Research & Development and Co-Director Center for Population Health Sciences, The University of Edinburgh - Yan Song
Associate Director, Bioanalysis Operations, AbbVie - Devry Spreitzer
Director, Global Electronic Systems Quality Assurance, Astellas - Jason Swift
Head R&D Information UK, AstraZeneca - Kevin Teburi
Director – iMed Team Leader, R&D Information, AstraZeneca - Simon Thornber
Director, Data Analytics, Informatics and Innovation, GlaxoSmithKline - Tjeerd Van Staa
Professor of Health eResearch, University of Manchester
Koalas, Chlamydia, Antibiotics and Microbiomes – what else do you need?
Katie Dahlhausen, a PhD student in my lab, has become really really interested (perhaps a bit obsessed) with a really interesting case study regarding koalas, Chlamydia, antibiotics, and microbiomes. Since we do not have funds to work on this in the lab, she has started an Indiegogo campaign to raise funds to work on this. For more information on this project and how Koalas, Chlamydia, antibiotics and microbiomes are connected see “The Koala Project” page.
https://www.indiegogo.com/project/the-koala-project/embedded/10753031 amzn_assoc_ad_type = “contextual”; amzn_assoc_tracking_id = “thtrofli-20”; amzn_assoc_marketplace = “amazon”; amzn_assoc_region = “US”; amzn_assoc_placement = “L2CQGSJAS2J24HJX”; amzn_assoc_linkid = “L2CQGSJAS2J24HJX”; amzn_assoc_emphasize_categories = “51569011, 1000, 13900861, 13900871, 301668, 2619533011, 229534, 3375251”; amzn_assoc_fallback_products = “0879696842”; amzn_assoc_width = “400”; amzn_assoc_height = “90”; //z-na.amazon-adsystem.com/widgets/q?ServiceVersion=20070822&Operation=GetScript&ID=OneJS&WS=1&MarketPlace=US&source=ac
Michael Fischbach at #UCDavis 5/15 noon: Insights from a global view of secondary metabolism: Small molecules from the human microbiota
FridayGBSF 1005
Noon
Dr. Michael Fischbah of UCSF
"Insights from a global view of secondary metabolism: Small molecules from the human microbiota”



